Novobiocin-Sepharose was prepared by coupling of novobiocin to Epoxy-activated Sepharose 6B and used as an affinity adsorbent. Four novobiocin-binding proteins were isolated from crude extracts of Escherichia coli with molecular weights of 105, 92, 85, and 40 kdal. The two larger proteins were identified as the A subunit (gyrA protein) and the B subunit (gyrB protein) of DNA gyrase (topoisomerase II). By this method the two gyrase components can be easily separated and purified in high yield. Although both proteins are involved in the ATP-dependent supercoiling of relaxed plasmid DNA, only the gyrB protein is required for catalyzing the cleavage of ATP. The gyrB protein ATPase activity is competitively inhibited by novobiocin and related coumarin antibiotics. ATP hydrolysis is unaffected by the addition of either gyrA protein or DNA but stimulated in the presence of both.
INTRODUCTION
Novobiocin and the related antibiotics coumermycin and clorobiocin are potent inhibitors of DNA replication in Escherichia coli (1, 2, 3) . The target of these coumarin drugs has been identified as the B subunit (gyrB protein) of DNA gyrase (topoisomerase II), an enzyme that introduces negative superhelical turns into relaxed covalently closed circular DNA (4) . Gyrase is considered to exist as a tetramer containing two each of the gyrA and gyrB gene products (5, 6 ). The energy for the supercoiling is derived from hydrolysis of ATP to ADP and P.^ and the ATPase activity of gyrase has been found to be stimulated by duplex DNA (7, 8, 9) . Kinetic data suggest that the coumarin drugs act as competitive inhibitors for ATP (8) .
More recently a related enzyme, topoisomerase II 1 , has been isolated, which is composed of the gyrA protein and a protein homologous to a portion of the gyrB protein. This enzyme relaxes supercoiled DNA but lacks both the supercoiling and the ATPase activity of DNA gyrase and shows no apparent interaction with ATP or novobiocin (10, 11) .
Studies on the catalytic properties of DNA gyrase have been hampered by difficulties in obtaining sufficient quantities of the purified subunits with conventional isolation procedures. We therefore attempted to exploit the strong interaction of gyrase with novobiocin for the purification of the enzyme. In this paper we describe the preparation of novobiocin-Sepharose and its use as an affinity adsorbent for novobiocin-binding proteins. It will be shown that both components of DNA gyrase can be easily purified by this method. Evidence will be presented that the gyrB protein contains a DNA-independent ATPase activity.
EXPERIMENTAL PROCEDURES
Preparation of novobiocin-Sepharose. 5 g Epoxy-activated Sepharose 6B (Pharmacia) were reswollen in 500 ml distilled water for 1 h at room temperature and washed on a sintered glass filter with 500 ml of 0.3 M Na-carbonate pH 9.5 (buffer A ) . The gel was then mixed with a solution of 500 mg novobiocin (Sigma) in 15 ml buffer A and gently shaken for 16 h in a 37 C water bath. Excess epoxy-groups were blocked by addition of ethanolamine (final concentration 1 M) and continued shaking for another 4 h at 37 C. The product was then washed alternately with 500 ml each of 0.5 M NaCl in buffer A, distilled water, 0.5 M NaCl in 0.1 M Na-acetate pH 4.0, and distilled water.
Enzyme purification. Frozen cells (230 g ) of E.coli H56O were lysed and a crude extract prepared as described by Bouche et al. (12) . All subsequent steps were performed at 0-4°C. For removal of ribosomes the Mg-acetate concentration of the crude extract was adjusted to 5 mM and the extract was centrifuged for 4 h at 30 OOO rpm in a Beckman 45 Ti rotor. Solid ammonium sulfate was added to the supernatant to give a 37% saturation (0.226 g/ml) and after stirring for 2 h the precipitate was removed by centrifugation for 30 min at 1O OOO rpm and discarded. The ammonium sulfate concentration of the supernatant was adjusted to 42% saturation by adding O.O61 g/ml. After another 2 h the precipitate was collected by centrifugation and dissolved in 23 ml 2 5 mM Hepes pH 8.0 -1 mM dithiothreitol -1 mM EDTA -1 0 % (w/w) ethylene glycol -50 mM KC1 (buffer B ) . The 37-42 % ammonium sulfate fraction was dialysed against buffer B and loaded on a HeparinSepharose C1-6B column (2.6 x 15 cm) equilibrated with the same buffer. The column was washed with buffer B and then developed with a 400-ml linear gradient of 0.05-0.8 M KC1. Topoisomerase I was eluted between 0.7 and 0.8 M KC1 and was further purified by phosphocellulose, hydroxyapatite, and DNA agarose chromatography as described by Depew et al. (13) . Topoisomerase II activity as detected by complementation tests and supercoiling assays (see below) was eluted as a broad peak between 0.3 and 0.5 M KC1. Active fractions were pooled and further fractionated by affinity chromatography on novobiocin-Sepharose as described in the legend to Fig. 2 . Protein content was determined by the method of Spector (14) with bovine serum albumin as a standard.
Preparation of relaxed ColEI DNA. The reaction mixture (5ml) contained 25 mM Hepes pH 8.0, 50 mM KC1, 10 mM Mg-acetate, 1 mM dithiothreitol, 0.6 mM ATP, 1 mg supercoiled ColEI DNA, 5 units T4 DNA ligase (Boehringer), and 500 units topoisomerase I. A unit of topoisomerase I is defined as the amount of activity that relaxes 1 yg of supercoiled ColEI DNA in 30 min at 30°C. After a 2 h incubation at 30°C the reaction was stopped by addition of an equal volume of phenol and the relaxed DNA was concentrated from the aqueous phase by ethanol precipitation.
Supercoiling assay. Reaction mixtures (25 yl) contained 25 mM Hepes pH 8.0, 25 mM KC1, 7 mM Mg-acetate, 2 mM spermidine-HCl, 2 mM ATP, 5 mM dithiothreitol, 2.5 yg E.coli tRNA, and 2.5 yg relaxed ColEI DNA. Incubations were carried out for 30 min at 30°C. The reaction was stopped by adding an equal volume of phenol and 10 yl of the aqueous phase were loaded on agarose gels (0.8 % ) and run at 35 V for 14 h (15) . A unit of gyrase is defined as the amount of activity that supercoils 1 yg of relaxed ColEI DNA in 30 min at 30°C.
ATPase assay. Reaction conditions were as described for the supercoiling assay except that tRNA and relaxed ColEI DNA were omitted. The amount of inorganic phosphate released was deter-mined colorimetrically by formation of a Malachite Green-phosphomolybdate complex (16) . One unit of ATPase releases 1 nmol P.^ in 30 min at 30°C.
Complementation test. This assay measures the complementation of ColEl DNA replication in extracts from the thermosensitive gyrB mutant LE316 (17) or from thermosensitive gyrA mutants (18) . Reaction mixtures (25 yl) contained 40 mM Hepes pH 8.0, 100 mM KC1, 11 mM Mg-acetate, 15 mM creatine phosphate, 2.5 yg creatine kinase (Boehringer), 2 mM ATP, 0.4 mM each of CTP, GTP, and UTP, 0.05 mM CAMP, 0.025 mM each of dATP, dCTP, dGTP and 3 H-dTTP (500 cpm x pmol" 1 ), 2 yg ColEl DNA, plus extract (approximately 10 mg protein per ml assay mixture). Incubations were performed for 60 min at 30°C and the amount of 3 H-dTMP incorporated into acid-insoluble material determined as described previously (18) .
RESULTS

Affinity chromatography
For the design of a biospecific affinity adsorbent for DNA gyrase we took advantage of the strong interaction between novobiocin and the gyrB subunit of the enzyme. The immobilization of the drug was carried out by coupling it to Epoxy-activated Sepharose. This coupling gel contains reactive oxirane groups that can form stable ether bonds with nucleophilic hydroxy and amino groups of the ligand (19) . Under weakly alkaline conditions coupling will occur primarily at the phenolic hydroxy group of the 4-hydroxy-3(3-methyl-2-butenyl)-benzoic acid moiety of novobiocin (see Fig. 1 ). Various structural modifications are possible in this part of the molecule without loss of the biological activity (20) . Furthermore the 1,4-butandiol-diglyceryl ether residue connecting the ligand with the matrix provides a hydrophilic spacer arm that should minimize any interference of the matrix with the binding reaction between the immobilized drug and the target protein (s) . The molecular weights of the two larger novobiocin-binding proteins correspond closely to those reported previously for the A and B subunits of DNA gyrase (7, 21) . This assignment was confirmed by complementation tests with extracts from conditional lethal gyrA and gyrB mutants (18) . The densitometer tracings shown in Fig. 3 demonstrate that both gyrase components can be eluted in an electrophoretically pure form from the novobiocinSepharose after carrying out a prior Heparin-Sepharose chromatography. The two proteins were obtained in similar quantities with a yield of 2.0 mg (A subunit) and 2. larger amount of E.coli cells (7, 9) . It should be noted however that whereas the gyrB protein adsorbed quantitatively to the novobiocin-Sepharose a large fraction of the gyrA complementing activity did not bind to the column and was found in the flow-through.
Catalytic properties
The purified gyrA and gyrB protein preparations were tested for supercoiling of relaxed ColE1 DNA (Fig. 4 ) . Neither protein It has been stated previously that all enzymatic activities attributed to DNA gyrase require the presence of both subunits A and B (22) . However, when we assayed our protein preparations for ATPase activity, we found consistently that the gyrB protein contains by itself a novobiocin-sensitive ATPase activity. This ATPase co-sedimented with the gyrB complementing activity in a sucrose gradient with a sedimentation coefficient s o~ = 5.0 as expected for gyrB protomers (23) . Fig. 5 shows that the gyrB protein ATPase exhibits a sigmoidal concentration dependence urable extent. With respect to the sugar moiety the enzyme is less specific and dATP (but not araATP) was also hydrolysed although with only 25% of the rate of ATP (data not shown).
Novobiocin has been shown to inhibit gyrase function by interfering with the binding of ATP to the gyrB protein (7) . Hence, we determined the inhibitory effect of novobiocin on ATP-cleavage catalyzed by gyrB protein at three different ATP concentrations (Fig.7) . The results presented as a Dixon plot (24) indicate a competitive interaction between ATP and novobiocin and give a Kv alue of 3.5 x 10~ for novobiocin. The K L obtained for clorobiocin is nearly identical with that of novobiocin, whereas coumermycin appears to be an even more potent inhibitor with a _ Q K^ in the range of 8 x 10 . On the other hand, oxolinic acid has no inhibitory effect on the ATPase activity of the gyrB protein (data not shown).
ATPase activity was also detected in the ATP-eluate of the novobiocin-Sepharose column. This activity was nevertheless dif- ferent from the gyrB protein ATPase, since it was insensitive to high concentrations of novobiocin (500 ug/ml) and was unaffected by the combined addition of gyrA protein and DNA (data not shown).
DISCUSSION
In this paper we have shown that affinity chromatography on novobiocin-Sepharose can be employed as a simple and efficient purification procedure for both subunits of DNA gyrase. The gyrA and the gyrB protein differ clearly in their mode of interaction with the immobilized drug. While gyrB protein binds quantitatively to the affinity adsorbent, only a portion of the gyrA protein is retained -the amount of which is roughly equimolar to the total amount of gyrB protein. In contrast to the tightly bound gyrB protein, the gyrA protein is readily eluted by an increase in the ionic strength of the buffer. These findings taken together suggest that the gyrA protein does not bind by itself to novobiocin but as a component of a gyrA-gyrB protein complex. Dissociation of this complex in high salt would consequently lead to the elution of the gyrA component leaving the gyrB protein attached to the adsorbent.
Since novobiocin appears to act as a competitive inhibitor of ATP binding to DNA gyrase (7, 8) , we attempted to use ATP as a specific eluting agent. However, it turned out impossible to desorb the gyrB protein by affinity elution with ATP. This would imply that the drastic difference in binding strength between ATP and novobiocin had not been significantly reduced by coupling the drug to Epoxy-activated Sepharose. Unexpectedly it was found that a 85-kdal protein can be eluted from the affinity adsorbent with ATP-buffer. The function of this protein, which appears to be a major novobiocin-binding protein of E.coli, has still to be clarified.
As a consequence of its extremely strong binding to novobiocin, the desorption of the gyrB protein requires the unfolding of the polypeptide chain in 5 M urea. The denaturation is however reversible, and full recovery of gyrB complementing activity is obtained upon removal of urea (18) . Interestingly, a 40-kdal protein present in crude extracts resembles the gyrB protein in its tight binding to the immobilized novobiocin. The relationship between these two proteins is unclear. It has recently been shown, that a presumptive cleavage product of the gyrB protein with a molecular weight of 50-kdal (designated v) can functionally interact with the gyrA protein as a component of topoisomerase II' (10, 11) . On the basis of these data it has been suggested that the gyrB protein consists of two domains one interacting with the gyrA protein and the other containing the ATP (and novobiocin) binding site (10) . It is therefore tempting to speculate that the 40-kdal novobiocin-binding protein is produced from the gyrB protein by the same proteolytic cleavage event that generates the 50-kdal subunit.
While both the gyrA and the gyrB protein are required for supercoiling of relaxed DNA, only the gyrB protein is necessary for the novobiocin-sensitive ATPase activity. The sigmoidal concentration dependence (see Fig. 5 ) indicates that the functional enzyme is an oligomer of the gyrB protomer. The stimulation of the ATPase activity by the combined addition of gyrA protein and duplex DNA may therefore result in part from the stabilization of gyrB dimers following the formation of gyrase-DNA complexes containing a tetrameric A 2 B~ protein (5, 6) . Apparently the DNAindependent ATPase activity of the gyrB protein has not been noticed previously because of the low enzyme and suboptimal substrate concentrations employed in earlier work. It is however questionable whether the gyrB protein ATPase has any physiological significance in itself. More likely this activity is modulated in the cell by association with the gyrA gene product (or some other proteins) to allow its utilization in energy-requiring reactions.
The possibility that the gyrB protein ATPase activity described in this work is dependent on traces of contaminating gyrA protein, not detected by gel electrophoresis or supercoiling assay, can be excluded for the following reasons: (1) Addition of an excess of gyrA protein has by itself no effect on the ATPase activity, (2) the enzyme is not stimulated by duplex DNA unless gyrA protein is also added, (3) the ATPase is defective in a gyrB protein prepared from a thermosensitive gyrB mutant but unaffected in a preparation from a thermosensitive gyrA mutant (to be published) .
The kinetic data indicate that the association of gyrB protein with gyrA protein bound to duplex DNA decreases the K for ATP without affecting V m a x . On the other hand, the coumarin drugs drastically increase the apparent K^ for ATP while likewise leaving V m a x unchanged. Thus by definition these antibiotics may be considered as competitive inhibitors of the gyrB protein ATPase with respect to ATP. The K± values obtained in the absence of gyrA protein and DNA are by roughly an order of magnitude higher than those reported by Sugino et al. (8) for the gyrase-DNA complex. Apparently complex formation increases the affinity of the gyrB protein for both ATP and the coumarin drugs. Nevertheless, considering the intricate interactions between the gyrB protomers and the various effectors and inhibitors the physical meaning of these kinetic parameters is problematical. Experiments are now in progress to describe more adequately the various interactions affecting the enzymatic activities of DNA gyrase.
Finally we wish to point out that affinity chromatograpny on novobiocin-Sepharose represents a generally applicable method for isolating novobiocin-blnding proteins from a wide variety of organisms. This procedure has already been employed successfully to isolate both subunits of DNA gyrase from Bacillus subtilis (to be published).
